Desmoplastic melanoma: a challenge for the oncologist

被引:7
作者
Manfredini, Marco [1 ]
Pellacani, Giovanni [1 ]
Losi, Lorena [2 ]
Maccaferri, Monia [3 ]
Tomasi, Aldo [3 ]
Ponti, Giovanni [3 ]
机构
[1] Univ Modena & Reggio Emilia, Dept Surg Med Dent & Morphol Sci Interest Transpl, Dermatol Unit, Modena, Italy
[2] Univ Modena & Reggio Emilia, Dept Pathol, Modena, Italy
[3] Univ Modena & Reggio Emilia, Dept Diagnost & Clin Med & Publ Hlth, Clin Pathol Unit, Modena, Italy
关键词
desmoplastic melanoma; lentigo maligna melanoma; mixed desmoplastic melanoma; NF1; pure desmoplastic melanoma; spindle cell melanoma; stromal collagenization; PRIMARY ACQUIRED MELANOSIS; MALIGNANT-MELANOMA; MELANOCYTIC NEVI; CONJUNCTIVAL MELANOMA; NEUROTROPIC MELANOMA; MUTATIONS; NEUROFIBROMATOSIS; CANCER; SKIN; EXPRESSION;
D O I
10.2217/fon-2016-0334
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Aim: To evaluate clinical, pathologic and genetic features of desmoplastic melanoma (DM). Materials & methods: Analysis of all DM records from 1991 to 2015. Results: The most common location of DMs was the head and neck (69%); median age and follow-up were 60.5 and 7.3 years, respectively. A familial predisposition for DMs and others malignancies was analyzed. Thin Breslow thickness (<4.5 mm) was associated with an intraepidermal component or a previous lentigo maligna, whereas high Breslow thickness (>4.5 mm) was observed in 'pure' DM. Conclusion: DM could progress from an early phase, characterized by an intraepidermal component, to late phase, characterized by a dermal nodule. This hypothesis correlates with melanoma genetic and NF1 mutation, which could be an early event in the progression of DM.
引用
收藏
页码:337 / 345
页数:9
相关论文
共 61 条
[1]   Reflectance confocal microscopy for plaque psoriasis therapeutic follow-up during an anti-TNF-α monoclonal antibody: an observational multicenter study [J].
Ardigo, M. ;
Agozzino, M. ;
Longo, C. ;
Lallas, A. ;
Di Lernia, V. ;
Fabiano, A. ;
Conti, A. ;
Sperduti, I. ;
Argenziano, G. ;
Berardesca, E. ;
Pellacani, G. .
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2015, 29 (12) :2363-2368
[2]   The Nf1 tumor suppressor regulates mouse skin wound healing, fibroblast proliferation, and collagen deposited fibroblasts [J].
Atit, RP ;
Crowe, MJ ;
Greenhalgh, DG ;
Wenstrup, RJ ;
Ratner, N .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1999, 112 (06) :835-842
[3]   The neurofibromatosis type 1 (Nf1) tumor suppressor is a modifier of carcinogen-induced pigmentation and papilloma formation in C57BL/6 mice [J].
Atit, RP ;
Mitchell, K ;
Nguyen, L ;
Warshawsky, D ;
Ratner, N .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2000, 114 (06) :1093-1100
[4]   Melanocytic nevi are associated with neurofibromas in neurofibromatosis, type I, but not sporadic neurofibromas. A study of 226 cases [J].
Ball, NJ ;
Kho, GT .
JOURNAL OF CUTANEOUS PATHOLOGY, 2005, 32 (08) :523-532
[5]  
BARNHILL RL, 1993, SEMIN DIAGN PATHOL, V10, P47
[6]   Desmoplastic melanoma associated with an intraepidermal lentiginous lesion: case report and literature review [J].
Bastos Junior, Cesar de Souza ;
Pineiro-Maceira, Juan Manuel ;
Belles de Moraes, Fernando Manuel .
ANAIS BRASILEIROS DE DERMATOLOGIA, 2013, 88 (03) :408-412
[7]   Desmoplastic melanoma: A 12-year experience with sentinel lymph node biopsy [J].
Broer, P. N. ;
Walker, M. E. ;
Goldberg, C. ;
Buonocore, S. ;
Braddock, D. T. ;
Lazova, R. ;
Narayan, D. ;
Ariyan, S. .
EJSO, 2013, 39 (07) :681-685
[8]   Distinction of desmoplastic melanoma from non-desmoplastic melanoma by gene expression profiling [J].
Busam, KJ ;
Zhao, H ;
Coit, DG ;
Kucukgol, D ;
Jungbluth, AA ;
Nobrega, J ;
Viale, A .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2005, 124 (02) :412-419
[9]   Cutaneous desmop astic melanoma - Reappraisal of morphologic heterogeneity and prognostic factors [J].
Busam, KJ ;
Mujumdar, U ;
Hummer, AJ ;
Nobrega, J ;
Hawkins, WG ;
Coit, DG ;
Brady, MS .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2004, 28 (11) :1518-1525
[10]  
CARLSON JA, 1995, CANCER, V75, P478, DOI 10.1002/1097-0142(19950115)75:2<478::AID-CNCR2820750211>3.0.CO